IGF binding protein (IGFBP)-3 has antiproliferative and proapoptotic effects on the growth of human
breast cancer cells in vitro. However, clinical studies suggest that high levels of
IGFBP-3 in
breast tumor tissue are associated with large, highly proliferative
tumors. In this study, we examined the effects of stable transfection with human
IGFBP-3 cDNA on the growth of T47D human
breast cancer cells in vitro and in vivo. Expression of
IGFBP-3 initially inhibited the growth of T47D in vitro but was associated with enhanced growth in vivo. Furthermore, IGFBP-3-expressing cells in vitro became growth stimulated at higher passages post transfection, suggesting
breast cancer cells may switch their response to
IGFBP-3 with increasing tumorigenicity. These stimulatory effects observed in IGFBP-3-expressing cells were associated with an enhanced responsiveness to the proliferative effects of
epidermal growth factor (
EGF). When
EGF receptor (EGFR)
kinase activity was blocked using
PD153035, high passage
IGFBP-3 transfectants were growth inhibited compared with controls treated with inhibitor. These findings suggest that the interaction between
IGFBP-3 and the EGFR system is central to whether
IGFBP-3 acts as a growth stimulator or inhibitor in
breast cancer cells and that
therapies targeting EGFR may have increased efficacy in
breast tumors expressing high levels of
IGFBP-3.